1. Home
  2. JG vs GANX Comparison

JG vs GANX Comparison

Compare JG & GANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JG
  • GANX
  • Stock Information
  • Founded
  • JG 2012
  • GANX 2017
  • Country
  • JG China
  • GANX United States
  • Employees
  • JG N/A
  • GANX N/A
  • Industry
  • JG Computer Software: Programming Data Processing
  • GANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JG Technology
  • GANX Health Care
  • Exchange
  • JG Nasdaq
  • GANX Nasdaq
  • Market Cap
  • JG 50.0M
  • GANX 45.8M
  • IPO Year
  • JG 2018
  • GANX 2021
  • Fundamental
  • Price
  • JG $8.29
  • GANX $1.80
  • Analyst Decision
  • JG
  • GANX Strong Buy
  • Analyst Count
  • JG 0
  • GANX 6
  • Target Price
  • JG N/A
  • GANX $8.33
  • AVG Volume (30 Days)
  • JG 32.7K
  • GANX 262.8K
  • Earning Date
  • JG 06-05-2025
  • GANX 05-13-2025
  • Dividend Yield
  • JG N/A
  • GANX N/A
  • EPS Growth
  • JG N/A
  • GANX N/A
  • EPS
  • JG N/A
  • GANX N/A
  • Revenue
  • JG $43,316,299.00
  • GANX N/A
  • Revenue This Year
  • JG $10.90
  • GANX N/A
  • Revenue Next Year
  • JG N/A
  • GANX N/A
  • P/E Ratio
  • JG N/A
  • GANX N/A
  • Revenue Growth
  • JG 8.94
  • GANX N/A
  • 52 Week Low
  • JG $2.36
  • GANX $0.89
  • 52 Week High
  • JG $20.94
  • GANX $3.65
  • Technical
  • Relative Strength Index (RSI)
  • JG 40.56
  • GANX 46.13
  • Support Level
  • JG $7.79
  • GANX $1.64
  • Resistance Level
  • JG $9.00
  • GANX $1.80
  • Average True Range (ATR)
  • JG 0.59
  • GANX 0.18
  • MACD
  • JG -0.12
  • GANX 0.01
  • Stochastic Oscillator
  • JG 16.56
  • GANX 62.75

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.

Share on Social Networks: